Advanced Medical Solutions (GB:AMS) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Advanced Medical Solutions Group plc (AMS) has announced that as of May 31, 2024, their issued share capital comprises 217,508,089 ordinary shares with voting rights, a key figure for shareholders to determine notification requirements for their interest changes as per the FCA’s Disclosure and Transparency Rules. AMS, a world-leading developer and manufacturer of innovative tissue-healing technology, has a broad product portfolio marketed under various brands, and operates globally with a network of partners and direct sales forces. With a focus on quality outcomes for patients and value for payers, the company has made six acquisitions since 2019, expanding its technological and geographical footprint.
For further insights into GB:AMS stock, check out TipRanks’ Stock Analysis page.